Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Osteoporosis (Conference News)
Alendronate Plus HRT Increased Bone Mass Compared to HRT Alone
September 28th, 1998
Post-menopausal women with osteoporosis taking hormone replacement therapy (HRT) obtained greater increases in bone mass when FosamaxR (alendronate sodium) was added to their treatment, according to new research presented at the European Congress on Osteoporosis. "Questions about the efficacy and safety of combined therapy with HRT and Fosamax are among the most frequent questions I hear from physicians and patients alike," said Robert Lindsay, MD, chief of Internal Medicine and Endocrinology, Helen Hayes Hospital, and president of the U.S. National Osteoporosis Foundation. "Until now, we've had to rely on mostly anecdotal experience about the combination of...
Source: Women's Health Weekly (1998-09-28)
|
